Gilead Looks to Simplify HIV Treatment By Combining Two Leading Drugs In One Pill
Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV who are on complex treatment regimens, according to BMO Capital Markets.
Gilead Looks to Simplify HIV Treatment By Combining Two Leading Drugs In One Pill Read More »
